Quick Search

 

 


 

 

Result Summary for 111733

Result Summary
Protocol ID: 111733
Clinical Study ID: NKG111733
Official Title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects with Major Depressive Disorder
Phase: phase 2
Study Indications or Diseases:
  • Depressive Disorder, Major
Generic Name: orvepitant
Trade/Product Name: orvepitant
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.